Variations of Proline-Rich Kinase Pyk2 Expression Correlate with Prostate Cancer Progression
暂无分享,去创建一个
R. Franco | P. Chieffi | S. Staibano | J. Schlessinger | V. Mirone | A. Palmieri | C. Imbimbo | A. Picascia | D. Tramontano | R. Stanzione | G. Rosa
[1] W. Marston,et al. Overexpression of the focal adhesion kinase (p125FAK) in the vascular smooth muscle cells of intimal hyperplasia. , 2001, Journal of vascular surgery.
[2] W. Xie,et al. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the noble rat , 2000, The Prostate.
[3] E. Reiter,et al. Genes upregulated during castration‐induced rat prostatic apoptosis: cloning and characterization of new cDNAs , 2000, BJU international.
[4] H. Ueda,et al. Suppression of Pyk2 Kinase and Cellular Activities by Fip200 , 2000, The Journal of cell biology.
[5] H. Husson,et al. RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells , 1999, Oncogene.
[6] Y. Hsieh,et al. Racial differences in prostate cancer related to loss of heterozygosity on chromosome 8p12-23. , 1999, International journal of radiation oncology, biology, physics.
[7] T. Udayakumar,et al. Culture of prostate epithelial cells of the rhesus monkey on extracellular matrix substrate: influence of steroids and insulin-like growth factors. , 1999, The Journal of endocrinology.
[8] J. Moul. Angiogenesis, p53, bcl-2 and Ki-67 in the Progression of Prostate Cancer after Radical Prostatectomy , 1999, European Urology.
[9] William Arbuthnot Sir Lane,et al. Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS , 1999, Current Biology.
[10] M. Burdick,et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.
[11] P. Majumder,et al. Activation of p38 Mitogen-activated Protein Kinase by PYK2/Related Adhesion Focal Tyrosine Kinase-dependent Mechanism* , 1999, The Journal of Biological Chemistry.
[12] C. Dinney,et al. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] P. Majumder,et al. Bcl-xL Blocks Activation of Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2 and Stress-activated Protein Kinase/c-Jun N-terminal Protein Kinase in the Cellular Response to Methylmethane Sulfonate* , 1999, The Journal of Biological Chemistry.
[14] T. Visakorpi. New pieces to the prostate cancer puzzle , 1999, Nature Medicine.
[15] Noah Craft,et al. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.
[16] M. Šuša. Heterotrimeric G proteins as fluoride targets in bone (review). , 1999, International journal of molecular medicine.
[17] G. Miller,et al. Molecular genetics and epidemiology of prostate carcinoma. , 1999, Endocrine reviews.
[18] A. Hagemeijer,et al. Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines , 1999, Urological Research.
[19] J. Trapman,et al. Identification of a homozygous deletion at 8p12–21 in a human prostate cancer xenograft , 1999, Genes, chromosomes & cancer.
[20] H. Frierson,et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression. , 1999, Cancer research.
[21] T. Hunter,et al. Pyk2 and Src‐family protein‐tyrosine kinases compensate for the loss of FAK in fibronectin‐stimulated signaling events but Pyk2 does not fully function to enhance FAK− cell migration , 1998, The EMBO journal.
[22] J. Guan,et al. Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. , 1998, European journal of biochemistry.
[23] C. Chatelain,et al. Androgen Deprivation for Prostatic Carcinoma: A Rationale for Choosing Components , 1998, International journal of urology : official journal of the Japanese Urological Association.
[24] Zhong-ying Liu,et al. Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells , 1998, Journal of Virology.
[25] J. Schlessinger,et al. Identification of a New Pyk2 Isoform Implicated in Chemokine and Antigen Receptor Signaling* , 1998, The Journal of Biological Chemistry.
[26] R. Ganju,et al. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. , 1998, Blood.
[27] B. Wullich,et al. Androgen Receptor Expression, Proliferation Index and Aneuploidy in Tissue Explant Cultures Derived Prostate Carcinoma Cells Co-Cultivated on Membranes , 1998, European Urology.
[28] P. Stricker,et al. Growth factor involvement in progression of prostate cancer. , 1998, Clinical chemistry.
[29] D. Mukhopadhyay,et al. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. , 1998, Cancer research.
[30] A. Schönthal,et al. Expression of Human Prostatic Acid Phosphatase Correlates with Androgen-stimulated Cell Proliferation in Prostate Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.
[31] C. Wood,et al. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. , 1998, British Journal of Cancer.
[32] R. Ganju,et al. Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. , 1998, Blood.
[33] J. Guan,et al. Differential Regulation of Pyk2 and Focal Adhesion Kinase (FAK) , 1998, The Journal of Biological Chemistry.
[34] O. Cussenot,et al. Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro , 1997, International journal of cancer.
[35] J. Parsons,et al. Induction of Apoptosis after Expression of PYK2, a Tyrosine Kinase Structurally Related to Focal Adhesion Kinase , 1997, The Journal of cell biology.
[36] J. Kozlowski,et al. Intrinsic and extrinsic factors controlling benign prostatic growth , 1997, The Prostate.
[37] R. Ganju,et al. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. , 1997, The Journal of clinical investigation.
[38] S. Lev,et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.
[39] L. Bégin,et al. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma , 1996, International journal of cancer.
[40] O. Jänne,et al. Effects of mitogens on androgen receptor-mediated transactivation. , 1996, Endocrinology.
[41] N. Kakazu,et al. Precise localization of the human gene encoding cell adhesion kinase β (CAKβ/PYK2) to chromosome 8 at p21.1 by fluorescence in situ hybridization , 1996, Human Genetics.
[42] S. Lev,et al. Activation of Pyk2 by Stress Signals and Coupling with JNK Signaling Pathway , 1996, Science.
[43] S. Chevalier,et al. Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo. , 1996, Molecular endocrinology.
[44] L. Mazzucchelli,et al. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. , 1996, The American journal of pathology.
[45] H. Kung,et al. A tyrosine kinase profile of prostate carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] H. Klocker,et al. Regulation of prostatic growth and function by peptide growth factors , 1996, The Prostate.
[47] Terukatsu Sasaki,et al. Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.
[48] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[49] W. Cance,et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. , 1995, Cancer research.
[50] G. Bubley,et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.
[51] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[52] P. Humphrey,et al. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate‐specific antigen levels , 1993, Cancer.
[53] J. Parsons,et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[55] C. Eaton,et al. Regulation of prostatic growth , 1988 .
[56] S. Hsu,et al. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.
[57] Daniel S. Miller,et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[58] R. Vessella,et al. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. , 1999, Urology.
[59] K. Griffiths,et al. The regulation of prostatic growth , 1996 .
[60] Myron Tanncnbaum,et al. Urologic pathology: The prostate , 1977 .
[61] D. Gleason,et al. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. , 1974, The Journal of urology.